Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
115.61
-0.32 (-0.28%)
Nov 21, 2024, 10:45 AM EST - Market open
Abbott Laboratories Analyst Ratings
Total Analysts
16
Consensus Rating
Buy
Price Target
$129.25
Upside
+11.80%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $143 → $149 | Buy | Maintains | $143 → $149 | +28.88% | Nov 5, 2024 |
| Bernstein | Bernstein | Buy Maintains $133 → $138 | Buy | Maintains | $133 → $138 | +19.37% | Oct 17, 2024 |
| UBS | UBS | Strong Buy Maintains $143 → $146 | Strong Buy | Maintains | $143 → $146 | +26.29% | Oct 17, 2024 |
| Jefferies | Jefferies | Hold Maintains $120 → $125 | Hold | Maintains | $120 → $125 | +8.12% | Oct 17, 2024 |
| Mizuho | Mizuho | Hold Maintains $115 → $130 | Hold | Maintains | $115 → $130 | +12.45% | Oct 17, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $131 → $133 | Buy | Maintains | $131 → $133 | +15.04% | Oct 17, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $107 → $117 | Hold | Maintains | $107 → $117 | +1.20% | Oct 17, 2024 |
| Raymond James | Raymond James | Buy Maintains $122 → $129 | Buy | Maintains | $122 → $129 | +11.58% | Oct 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $125 → $130 | Buy | Maintains | $125 → $130 | +12.45% | Oct 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $130 | Buy | Initiates | $130 | +12.45% | Oct 8, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $120 → $124 | Buy | Maintains | $120 → $124 | +7.26% | Oct 1, 2024 |
| Jefferies | Jefferies | Hold Reiterates $120 | Hold | Reiterates | $120 | +3.80% | Sep 26, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $131 | Buy | Initiates | $131 | +13.31% | Sep 19, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $112 → $120 | Strong Buy | Maintains | $112 → $120 | +3.80% | Aug 27, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $119 → $127 | Strong Buy | Maintains | $119 → $127 | +9.85% | Aug 22, 2024 |
| Barclays | Barclays | Buy Maintains $140 → $143 | Buy | Maintains | $140 → $143 | +23.69% | Jul 29, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.